Fever in very young infants is a common and important problem. Neonates have unique vulnerabilities to infection because of their immature immune systems and incomplete barriers to invasion. The rate of serious bacterial illnesses (SBIs) in young febrile infants has been reported to be between 8.5% and 12%. [1] [2] [3] Before 1985, it was recommended that all febrile infants (Ͻ60 days of age) be hospitalized and treated with parenteral antibiotic therapy after a full sepsis evaluation, because various criteria used to identify "high-risk" infants were insufficiently sensitive to identify all infants with SBIs. [4] [5] [6] However, the approach of hospitalizing and treating all febrile young infants with empiric antibiotic therapy had the disadvantages of unnecessary hospitalizations, nosocomial infections, injudicious use of antibiotics, emergence of resistant bacteria, and adverse effects of antibiotics. 7, 8 During the late 1980s and early 1990s, investigators changed strategies and attempted to identify febrile infants who were at low risk for SBIs and might be treated with close observation (inpatient or outpatient) without antibiotic treatment. 3, [9] [10] [11] [12] [13] [14] [15] [16] After the development of various low-risk criteria, several groups undertook studies to validate the criteria in their own populations. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] The designs of those studies alternated between retrospective and prospective, with variable approaches to empiric use of ceftriaxone. We hypothesized that prospective studies that implemented a strategy of observation without antibiotic treatment for low-risk infants, thereby relying on meticulous evaluation and careful decision-making, would show significantly better performance of low-risk criteria than would studies that continued to treat all patients (prospectively or retrospectively), regardless of risk stratification.
METHODS
We searched the English-language literature for original articles studying low-risk criteria for SBIs in febrile infants between 0 and 90 days of age. A National Library of Medicine PubMed database search for articles was performed by using combinations of the following search terms: "low risk criteria," "criteria," or "risk"; "serious bacterial illness," "serious bacterial infection," "bacterial infection," or "bacteremia"; and "fever" or "fever without source".Studies were limited to humans, infants, and publication after 1985.
The search criteria identified 740 articles. Bibliographic references from the relevant studies (original research and review articles) were reviewed for additional citations. Articles were excluded on the basis of abstracts if they focused on infants Ͼ90 days of age, patients with underlying conditions (such as patients with sickle cell disease, neutropenia, malignancy, central vascular catheters, or other immunocompromised states), or patients with a single focus of bacterial infection (eg, urinary tract infection [UTI] or meningitis). Sixty-three publications were reviewed carefully for inclusion criteria, definition of SBIs, and evaluations performed for study patients. The components of the low-risk criteria used in each study were reviewed and compared with the original Rochester Criteria 9 (Tables 1 and 2 ). Studies with overlapping subjects were excluded.
Articles were grouped according to type of study, and total patients were aggregated. The categories of studies were prospective without antibiotic treatment of low-risk infants, prospective with antibiotic treatment of lowrisk infants, and retrospective.
Portions of studies using different management plans for low-risk infants were classified accordingly. Data were extracted from the tables and text of each study and included the number of low-risk infants, the number of highrisk infants, the number of SBIs in each group, types of SBIs, and the outcomes of low-risk infants with SBIs. The random-effects method described by DerSimonian and Laird 28 was used to estimate overall relative risks (RRs) and corresponding 95% confidence intervals (CIs). This method accounts for the heterogeneity of studies through a statistical parameter representing interstudy variation.
Heterogeneity between studies was assessed by using the Q statistic, as well as graphic techniques. The ␤-binomial model for overdispersed data 29 was used to estimate pooled rates of SBIs for low-and high-risk patients. Comparison of pooled rates between groups was performed by using a likelihood ratio test. Linear regression analysis was used to evaluate the trend in the proportions of infants designated as being at low risk over time.
RESULTS
Twenty-one studies met inclusion criteria; 14 were prospective studies (Tables 3 and 4) and 7 were retrospective (Table 5) . 3, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] 30 Among the prospective studies, 9 treated low-risk patients empirically with antibiotics, 4 monitored low-risk patients without antibiotic treatment, and 1 used both strategies. The type of low-risk criteria was categorized, with 10 studies using variations of the Rochester criteria, 6 studies using Philadelphia criteria (2 comparing Rochester criteria with Philadelphia criteria), 2 studies using Boston criteria, 1 study using Pittsburgh criteria, 1 study using Milwaukee criteria, and 3 studies using "clinical impression of sepsis" or "not ill" descriptions (Tables 1 and 2 ). Studies were performed between 1979 and 1999. One study 12 included only children in the low-risk category, without a high-risk comparison group. Fever was defined as a temperature of Ͼ38.2°C in 1 study, 11 Ͼ38.1°C in 3 studies, 15, 20, 27 and Ͼ38.0°C in the rest of the studies.
SBIs included bacteremia, meningitis, bacterial diarrhea, pneumonia, and UTIs. 31 The defining characteristics for each type of infection varied slightly between the studies, most notably in the definition of UTI. Two studies accepted bagged urine specimens for culture, resulting in 8 diagnoses of UTIs in low-risk patients. 13, 19 Ten studies diagnosed UTIs in patients with catheterized urine cultures with Ͻ50 000 colony-forming units of a single organism per milliliter. 11, 12, 14, 17, 18, [20] [21] [22] [23] 25 Four studies provided no microbiologic definition of UTI or description of urine collection methods. 3, 15, 16, 30 Another variation was the inclusion of pneumonia as a SBI without microbiologic documentation. All infants studied were between 0 and 90 days of age. Six studies included only infants in the first month of life, and 4 studies excluded infants in the first month of life. The majority of studies were limited to the first 2 months of life, with 6 studies extending to 3 months. A summary of the prospective studies in which patients underwent observation alone is shown in Table 3 . 10, 11, 18, 19, 22 A total of 1858 patients were included, and 870 were classified as being at low risk. Six patients with SBIs were missed, including 2 patients with bacteremia and 4 patients with UTIs. The first child with bacteremia received parenteral antibiotic treatment within 24 hours after presentation and recovered uneventfully. 11 The identity of the organism was not noted. The second child had a blood culture positive for Yersinia enterocolitica and fared well after treatment. 18 The authors noted that a confirmatory culture was not performed before initiation of treatment. Three urine specimens obtained with sterile technique yielded either group B streptococcus or Escherichia coli. 18 Those patients fared well with treatment. One urine specimen collected by bag yielded E coli. 19 An analysis examining the proportion of infants designated as low risk in all studies showed a significant trend toward assigning fewer infants to the low-risk category over time ( ϭ Ϫ0.67; P ϭ .001). The slope parameter of the linear regression model of the proportions of infants designated as low risk by time (year) was Ϫ0.015 (P Ͻ .001). Early studies placed ϳ60% of children in the low-risk category. By the middle 1990s, only 30% of children were considered at low risk, as illustrated in Fig 1. 
DISCUSSION
The impetus for this study was the apparent discrepancy in the rate of SBIs among low-risk febrile infants reported in the literature. Previous studies reported a range of rates of SBIs in low-risk infants of 0% to 8.3%. 10, 15, 22, 26 This can be explained, in part, by the different sets of criteria used by various investigators (Table  2) . 3, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] 30 We showed that the rates of SBIs in low-risk patients in both retrospective studies and prospective studies using empiric antibiotic treatment were the same (2.7%) and were significantly different from the rate of SBIs in low-risk patients in prospective studies in which antibiotics were withheld (0.67%). We hypothesized that the low-risk criteria would function best when used in prospective studies in which lowrisk patients underwent observation alone. Without reliance on empiric antibiotic treatment, it would be essential to capture all infants at risk of early deterioration in the high-risk group. Careful sample collection, as well as meticulous physical examination, excluded infants with SBIs from the low-risk group.
For physicians to rely on clinical algorithms, they must be convinced that patients will not be placed in jeopardy. The clinical predictability provided by low-risk criteria will be deemed satisfactory if the children identified as being at low risk either do not have a SBI or remain in stable condition until the SBI is recognized. In prospective trials that treated lowrisk infants with observation alone, the low-risk criteria "missed" SBIs in 6 patients (bacteremia in 2 patients and UTIs in 4 patients). One of the cases involved a positive urine culture from a bagged specimen, which may represent a contaminant. These patients were treated with appropriate antibiotics when the cultures yielded positive results, and all recovered uneventfully. Therefore, careful application of these low-risk criteria was very effective in identifying children from whom empiric antibiotic therapy could be withheld.
Overall, data from 8540 infants were analyzed in this study. The total number of SBIs was 931, that is, 10.9%, consistent with rates commonly reported in the literature. With the use of low-risk criteria, ϳ30% of febrile infants can be identified as being at low risk for SBIs and can be treated with observation alone. These patients can be spared the negative effects that may be associated with empiric use of antibiotics, including cost, adverse effects of medications, development of resistant organisms, and psychosocial stresses on family dynamics. The criteria must be applied carefully to avoid misassignment of infants. Special attention should be given to the physical examination and medical history.
This study represents a comprehensive review of the literature that has evaluated the effectiveness of low-risk criteria in the identification of infants unlikely to have SBIs over the previous
FIGURE 1
Proportions of infants assigned to the low-risk category according to year of study initiation, with a statistically significant trend toward assignment of fewer infants to the low-risk category over time (P ϭ .001).
